Catalent (CTLT) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Catalent, Inc. Reports Second Quarter Fiscal Year 2017 Results
February 6, 2017 4:15 PM ESTQ2'17 revenue $483.7 million increased 6% as-reported, or 10% in constant currency from the prior year period. Q2'17 YTD revenue $925.9 million increased 5% as-reported, or 9% in constant currency from the prior year period. Announced the acquisition of Accucaps, a Canadian developer and manufacturer of over-the-counter (OTC) and prescription softgel products. Issued 380 million, 4.75% coupon, Euro notes with proceeds used to pay down debt and fund acquisitions; simultaneous re-price of our USD (50 bps rate reduction) and EUR (75 bps rate reduction) Term Loans.... More



